Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LVNG RX vs WePeptideRx

LVNG RX
Graded #268

Higher grade

vs+1.1000000000000014
WePeptideRx
Graded #295

Lower grade

The verdict

LVNG RX takes it — 62.5/100 to 61.4/100, but only just.

LVNG RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. LVNG RX is a Delaware-registered telehealth platform (LVNG RX LLC) offering compounded semaglutide from $149/mo and tirzepatide from $249/mo, plus a lower-dose GLP-1 microdose program. WePeptideRx is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLVNG RX +16
64
48
Dose & formulationEven
64
64
Clinical oversightWePeptideRx +25
56
81
Labs & monitoringLVNG RX +9
62
53
FulfillmentLVNG RX +2
69
67
Contract termsLVNG RX +6
61
55
LVNG RX · left barWePeptideRx · right bar

The numbers

MetricLVNG RXWePeptideRx
WeighScore62.5/10061.4/100
GradeCC
Scorecard rank#268#295
Semaglutide$149/mo (starting dose, compounded)$249/mo (compounded)
Tirzepatide$249/mo (microdose tier, starting dose, compounded)$249/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
LVNG RX

Graded #268 · C

Strengths

  • One bundled price covers the provider visit, prescription, shipping and ongoing check-ins, with zero consultation charges
  • States you are charged nothing if a provider does not approve you for treatment
  • Promises no dose-change surcharges — 'the price we quote is the price you pay, period'
  • Semaglutide from $149/mo is competitive against the wider compounded market
  • Offers a lower-dose GLP-1 microdose program alongside standard semaglutide and tirzepatide

Where it loses points

  • Displays a Trustpilot 'Rated Excellent 4.8 / 5' badge, but no Trustpilot profile exists for the domain or the brand
  • Also claims '4.9 based on 300+ Google reviews'; no Google listing for the business could be located
  • Its own homepage figures conflict — '10k+' members in the hero versus '1,743+ patients supported' in the counters below
  • The actual plan price is confirmed only after provider review, and the three treatment pages publish no prices at all
  • No compounding pharmacy, medical group or individual clinician is named anywhere on the site
WePeptideRx

Graded #295 · C

Strengths

  • Pre-mixed ready-to-inject delivery skips the vial reconstitution and sharps hassle of most compounded providers
  • Microdose protocols (0.05–0.25 mg sema, 0.5–2.5 mg tirz) suit ultra-low-dose maintenance patients — uncommon in DTC
  • 12+ programs under one platform — GLP-1 plus longevity, sexual wellness, and hair
  • Physical Boca Raton address, phone, and business hours listed
  • LegitScript Certified and publishes the FDA disclaimer

Where it loses points

  • Pharmacy partner not named
  • 48-state claim, but the specific state list isn't shown on the homepage
  • Medical director not named on the homepage
  • Telemedicine is outsourced to a third-party provider network rather than in-house staff
  • Corporate legal entity and arbitration venue not disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard